Terns Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	150.7	161.44	79.93	143.24	47.7	74.85
Short-Term Investments	144.94	196.73	183.51	139.88	118.28	-
Cash & Short-Term Investments	295.64	358.16	263.44	283.11	165.98	74.85
Cash Growth	-20.69%	35.96%	-6.95%	70.57%	121.74%	280.94%
Receivables	-	-	-	-	-	12.72
Prepaid Expenses	4.66	3.95	3.99	2.07	0.95	1.16
Other Current Assets	-	-	-	-	-	2.14
Total Current Assets	300.3	362.11	267.43	285.19	166.93	90.87
Property, Plant & Equipment	1	1.47	1.03	1.8	1.05	1.18
Other Long-Term Assets	0.36	0.35	0.06	0.04	0.09	0.25
Total Assets	301.65	363.93	268.52	287.03	168.07	92.29
Accounts Payable	2.95	2.15	2.52	1.65	2.13	0.94
Accrued Expenses	11.04	12.62	8.55	5.98	4.34	8.01
Short-Term Debt	-	-	-	-	-	12.88
Current Portion of Leases	0.46	0.43	0.6	0.66	-	-
Other Current Liabilities	0.94	0.46	0.28	0.19	0.36	1
Total Current Liabilities	15.39	15.65	11.94	8.47	6.82	22.82
Long-Term Leases	0.57	0.92	-	0.54	-	-
Other Long-Term Liabilities	1.63	1.49	1.21	1.07	0.95	0.88
Total Liabilities	17.59	18.06	13.15	10.08	7.77	23.7
Common Stock	0.01	0.01	0.01	0.01	0	-
Additional Paid-In Capital	778.07	767.62	588.01	520.18	342.71	14.6
Retained Earnings	-494.12	-421.48	-332.63	-242.42	-182.07	-131.92
Comprehensive Income & Other	0.11	-0.28	-0.02	-0.82	-0.34	-0.12
Total Common Equity	284.07	345.87	255.37	276.94	160.3	-117.44
Shareholders' Equity	284.07	345.87	255.37	276.94	160.3	68.59
Total Liabilities & Equity	301.65	363.93	268.52	287.03	168.07	92.29
Total Debt	1.03	1.35	0.6	1.21	-	12.88
Net Cash (Debt)	294.61	356.82	262.84	281.91	165.98	61.97
Net Cash Growth	-20.69%	35.76%	-6.77%	69.84%	167.82%	215.39%
Net Cash Per Share	3.22	4.49	3.69	7.82	7.31	217.33
Filing Date Shares Outstanding	90.08	87.3	64.65	56.67	25.27	25.13
Total Common Shares Outstanding	87.51	87.13	64.58	53.72	25.27	0.34
Working Capital	284.91	346.46	255.49	276.72	160.11	68.05
Book Value Per Share	3.25	3.97	3.95	5.16	6.34	-347.97
Tangible Book Value	284.07	345.87	255.37	276.94	160.3	-117.44
Tangible Book Value Per Share	3.25	3.97	3.95	5.16	6.34	-347.97
Machinery	-	1.36	1.38	1.4	1.3	0.97
Leasehold Improvements	-	0.75	0.73	0.76	0.93	0.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.